MB Venture Partners Scores another Investment Victory

Almost three years to the day after Memphis-based MB Venture Partners led the Series B round of financing for Nashville-based BioMimetic Therapeutics, the company has now gone public. To many people, the initial public offering of a small Nashville company that develops and commercializes bio-active drug-device combination products for the healing of musculoskeletal injuries and disease doesn’t seem like significant news for Memphis. However, in the ultra competitive biosciences field every success in the region should be viewed as important.

InMotion’s Initial Success Signals the Wisdom of its Formation

A mistake often made by organizations as well as communities is to try to be all things to all people. As Memphis expands its infrastructure and casts its line for businesses in the biosciences arena, it is important to initially stay close to its historical science cores.